Filter articles using the following links

GenSight Biologics Reports its Cash Position as of September 30, 2017

GenSight Biologics Appoints Barrett Katz as Chief Medical Officer

ESGCT, Berlin, Germany

GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy

Chardan Inaugural Gene Therapy Conference, NYC (US)

GenSight Biologics to Attend Chardan Gene Therapy Conference

GenSight Biologics integrates the Enternext® PEA-PME 150 index

5th Annual Targeting Ocular Diseases, Boston (MA)

GenSight Biologics integrates the CAC® Small, CAC® Mid and Small and CAC® All-Tradable Euronext indexes

EUNOS, Budapest, Hungary